コンテンツへスキップ
Merck

Beclomethasone dipropionate in the management of rhinitis--a review.

Annals of allergy (1982-09-01)
P Small, M Black, S Frenkiel, G N Wachs
要旨

Beclomethasone dipropionate has been demonstrated to be effective in the treatment of seasonal and perennial rhinitis. Comparative studies with other medications are lacking. Adverse reactions are frequent but minor. No alterations of the hypothalamic-pituitary-adrenal axis, nasal mucosal histology or bacterial and fungal flora have been recognized.

材料
製品番号
ブランド
製品内容

USP
ベクロメタゾン ジプロピオナート, United States Pharmacopeia (USP) Reference Standard
Supelco
ベクロメタゾン ジプロピオナート, analytical standard, for drug analysis
ベクロメタゾン ジプロピオナート, anhydrous, European Pharmacopoeia (EP) Reference Standard
システム適合性用ベクロメタゾンジプロピオナート, European Pharmacopoeia (EP) Reference Standard
ベクロメタゾン ジプロピオナート, European Pharmacopoeia (EP) Reference Standard